As Executive Director of HSCI, Brock Reeve works in partnership with the Faculty Directors, and has overall responsibility for the operations and strategy of the institute.
HSCI brings together the schools of Harvard University and all its affiliated hospitals and research institutions under a single mission: to use stem cells, both as tools and as therapies, to understand and treat the root causes of leading degenerative diseases. Under the leadership of the Executive Committee, HSCI invests in scientific research in seed grants, core facilities, and large-scale disease programs.
HSCI’s faculty membership has grown to over 350 Principal and Affiliated Faculty. The Institute is now engaged with several leading pharmaceutical companies in joint research projects, and its faculty have founded over 35 stem cell-related startup companies and serve on their Scientific Advisory Boards.
Reeve came to this role from the commercial sector, with extensive experience in both management consulting and operations for technology-based life science companies. His clients have included some of the leading pharmaceutical, biotechnology and medical device companies, and he has had hands-on operational responsibility in product management and marketing roles in software start-ups.
Brock received a B.A. and M.Phil. from Yale University and an M.B.A. from Harvard Business School.